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Coronavirus Transmission In the Dental Setting
Oral health professionals should remain up-to-date on the coronavirus, and clinical
measures to prevent its transmission in the dental setting.
By Susan H. Davide, RDH, MS, MSEd, Anty Lam, RDH, MPH and Christine Macarelli, RDH, MS
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EDUCATIONAL OBJECTIVES
After reading this course, the participant should be able to:
l. Describe the nature of coronaviruses, the types of illnesses they cause, and routes of
transmission.
2. Discuss the estimated incubation period for 2019 novel coronavirus (COVID-79). and risk
factors for various patient populations.
3. Explain appropriate clinical responses to the COVID-19 pandemic, and what oral health
professionals can do to prevent its spread in the dental setting.

INTRODUCTION
The 2079 novel coronavirus, which manifests as COVID-19, is described as the defining global
health crisis of our time. The most recent disease to be classified by the World Health
Organization as a pandemic, COVID-19 joins cholera, bubonic plague, smallpox and influenza as
among the most brutal killers in history. As researchers work to develop pharmaceutical
interventions for COVID-19, valiant efforts are being made worldwide to prevent or reduce
transmission. Health care professionals are facing unprecedented circumstances related to
patient care and growing concern about this deadly disease; for example, the American Dental
Association recommends that dental practices nationwide postpone elective procedures to
slow its spread.
This article reviews the emergence, transmission pathways and symptoms of COVID-19, and also
provides clinical strategies to help mitigate the pandemic. As a dental professional and
educator, I am confident this article will guide dental teams in complying with best practices
and providing care in accordance with U.S. Centers for Disease Control and Prevention
guidelines, ultimately protecting patients, staff and the community at large.

-Leann Keefer, ROH, BSEd, MSM
Director, Clinical Services
Crosstex International
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In late 2019, an outbreak of atypical pneumonia of
unknown cause presented in Wuhan in China's

Hubei Province. Upon investigation, the confirmed
cases were linked to a Wuhan market where wild

animals, including marmots, birds, rabbits, bats and

snakes, were being traded illegally. On December 31,
2019, the World Health Organization (WHO) was
notified of this outbreak by authorities in China.

Virological testing disclosed a novel coronavirus in

these patients, and, within a few weeks, WHO

tentatively named it as 2019 novel coronavirus (20192
nCoV).
On February 11, 2020, the International Committee on
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Taxonomy of Viruses announced the new name of the virus as severe acute respiratory
3
syndrome coronavirus, or SARS-CoV-2. This was chosen due to the virus being genetically
3
related to the coronavirus responsible for the SARS outbreak in 2003. On the same day, WHO
named the new disease COVID-19, following guidelines previously developed with the World

3
Organization for Animal Health and Food and Agricultural Organization of the United Nations.
Regardless of the nomenclature, this fast-spreading disease poses a global health risk.

Consequently, dental teams should remain up-to-date on its presentation, and clinical

measures to prevent its transmission in the dental setting.

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from respiratory

infections (including the common cold to flu-like or pneumonia symptoms), as well as
4
gastrointestinal symptoms - all which may or may not appear and range in severity. Middle
4
East respiratory syndrome (MERS-CoV) and SARS-CoV outbreaks continue to occur globally. A

novel coronavirus (nCoV) is a new strain that has not been previously identified in humans, and

is considered a zoonotic disease that spreads from animals to humans. Further investigations
determined the source of SARS-CoV transmission was from civet cats to humans and MERS-

CoV from dromedary camels to humans. Although the specific source of COVID-19 has not
been identified, bats and pangolins are currently implicated. As a novel coronavirus, the

information scientists have gathered about it may change as researchers and the medical
5
community continue to learn how the virus behaves.
The U.S. Centers for Disease Control and Prevention (CDC) reinforced the need for clinicians to
be watchful for exposure to COVID-19, not only with patients who are returning travelers from
areas with high incidence of the disease, but also with individuals who have come in contact
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TRANSMISSION
Cases of COVID-19 continue to spread globally. As of April 9, 2020, more than 1.5 million cases
78
had been reported worldwide, with 89,877 deaths. ' The disease has spread via travel from
8

China to at least 177 countries, with evidence of sustained transmission on six continents. As of
April 9, 2020, the United States had more than 395,000 confirmed cases across all 50 states, with
7,9,10

12,754 deaths.

Chinese officials confirmed the COVID-19 outbreak was associated with the Huanan Seafood
11

Market, a "wet market" in Wuhan. Wet markets sell live fish and animals, and have a history of
transmitting viruses. Typically, purchases are immediately slaughtered on site, which can cause
particles of infectious bacteria or viruses to become aerosolized and transmit from animals to
11

people. Investigators suspect that someone purchased contaminated meat, became sick
12

before or after consuming it, and spread the infection to others. Though the virus can spread
by consuming infected animals, it can also spread through coughing, sneezing and close
12

contact with an infected person or an object carrying the virus.

According to CDC officials, it may be possible to contract COVID-19 by touching a surface or
object that has the virus on it and then touching the mouth, nose or possibly eyes, but this is
12

not a confirmed primary mode of transmission. With most respiratory viruses, people are
12

typically considered most contagious when they present with acute symptoms.

Presently, it is

not clear how contagious those infected with the virus are during the incubation period;
however, there have been reports of transmission in individuals who show no signs or
13

symptoms of the disease.

SIGNS, SYMPTOMS AND PREVENTION
Signs and symptoms of COVID-19 are similar to other respiratory illnesses, and can include
runny nose, sore throat, fever, cough, shortness of breath, and breathing difficulties. In more
advanced cases, infections can lead to pneumonia, severe acute respiratory syndrome, kidney
414

failure and death. ·

Because the symptoms of the coronavirus are similar to that of other

common respiratory infections (such as a cold or flu), a definitive diagnosis can only be made
4,14

with a laboratory test.

15

The severity of symptoms in confirmed cases has ranged from no or mild symptoms to severe.

The incubation period - as reported by the CDC at presstime - is between two to 14 days from
15

exposure to the occurrence of disease signs and symptoms.

By comparison, WHO estimates
14

that incubation ranges between one and 12.5 days, with a median of five to six days. The
estimates for the incubation period for COVID-19 are based on previous observations with other
14,15

coronavirus diseases, such as SARS and MERS.
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The elderly and individuals who present with preexisting medical conditions, such as heart
disease, high blood pressure, cancer, diabetes or lung conditions, seem to experience more
15
serious complications. At this time, there is no research regarding the susceptibility of
76
pregnant women to the virus, and no evidence to suggest children are at increased risk.
On January 30, 2020, WHO classified the rapidly spreading outbreak as a Public Health
5,17
Emergency of International Concern, and on March 11 WHO declared it a pandemic. In
response to the outbreak, the CDC has partnered with health officials and health care systems
to reduce the impact of the virus and reinforce infection prevention principles. The CDC is using
a 2077 Morbidity and Mortality Weekly Report as a blueprint for community interventions and
1819
adapting it to COVID-19. · With no vaccine available to prevent coronavirus disease, the CDC
recommends everyday preventive actions to halt the spread of respiratory diseases, including
20
COVID-19 {Table 7).

TABLE 1.

Everyday Actions to Prevent the Spread of
Respiratory Diseases20
• Wash your hands often with soap and water for at least 20 seconds,
especially after going to the bathroom, before eating, and after blowing your
nose, coughing or sneezing.
• If soap and water are not readily available, use an alcohol-based hand sanitizer
with at least 60% alcohol. Always wash hands with soap and water if hands are
visibly dirty.
• Avoid close contact with people who are sick.
• Avoid touching your eyes, nose and mouth.
• Stay home when you are sick.
• Cover your mouth with a tissue when you sneeze and throw the tissue in the
trash.
• Clean and disinfe ct frequently touched objects and surfaces using regular
household cleaning sprays or wipes.
• In response to COVID-19, the U.S. Centers for Disease Control and Prevention
suggests that all individuals should wear cloth face coverings when out in public.
• People who show symptoms of COVID-19 should use face masks to help
prevent the spread of the disease.
• The use of face masks is crucial for health care workers and individuals who are
taking care of someone in close settings (at home or in a health care facility).

RESOURCES FOR CLINICIANS
The CDC maintains a comprehensive site for health care professionals that includes
preparedness resources to assist providers, clinics and hospitals when managing patients with
7
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The CDC also offers a clinical criteria form to guide evaluation for individuals under investigation
22
for COVID-19 based on what is known about MERS-CoV and SARS-CoV. In the event a person
under investigation for COVID-19 presents in dental practice, clinicians should immediately
notify the appropriate infection prevention personnel at their health care facility, as well as local
22
and state health departments.
The American Dental Association (ADA) and American Dental Hygienists' Association have
23, 24
issued statements and provided resources related to COVID-19.
As of presstime, each
organization also recommends that oral health professionals postpone elective and
nonemergency procedures, but remain available for dental emergencies that are considered
23 24
"potentially life threatening," according to the ADA. · Once active practice resumes, it will be
more important than ever for dental settings to follow standard precautions and infection
control, as outlined in the CDC's Guidelines for Infection Control in Dental Health-Care Settings
-2003.

25

TABLE 2.
Medical History
Interview

Recommendations for Minimizing Exposure to COVID-19 in Dental Settings 20
Questions to Ask Patient

Recommendations

Prior to
Appointment

• If "yes" to any one of these questions,
• Have you traveled outside of the coun� or within a geographical area
postpone patient care
that has a high incidence of COVID-19 In the last 14 days?
t
• Have you been in dose contact with anyone who has traveled outside • Advise paient to seek medical attention
the country or within a geographical area that has high incidences of
(if he/she has not already done so)
COVID-19 in the last 14 days?
• Instruct patient to reschedule when free
from signs/symptoms of ailment
• Do you have a cold or any respiratory issues?
• Do you have a fever or have you had a fever within the last 14 days?
• Do you have a sore throat?

Upon Arrival

• Same questions as above rf not able to interview patient prior to the
dental visft

Durin9
Appointment

• If the patient exhibits signs and symptoms during care (e.g., respiratory • Stop patient care
symptoms, cough, runny nose or feverish). diniaans should:
• Advise patient to seek medical attention
• Instruct patient to reschedule when free
from signs/ symptoms of ailment

• Same as above

Dental health care personnel (DHCP) who are in contact with patients, and whose
responsibilities include cleaning and disinfecting, handling contaminated supplies or
equipment, and who work in proximity to potentially contaminated surfaces, should diligently
20
follow all infection prevention procedures. To prevent infections from spreading during health
care delivery, an effective asepsis protocol - including administrative rules, engineering
controls, environmental hygiene, correct work practices, and appropriate use of personal
protective equipment (PPE) - is essential. The CDC provides infection control guidance for
20
health care settings. These are basic rationale and techniques familiar to DHCP for exposure
control, including hand hygiene. Recommendations for minimizing exposure to COVID-19 in the
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including SARS, MERS and endemic human coronaviruses, revealed that each can remain on
surfaces-such as metal, glass or plastic-for up to nine days. Surface disinfectant protocols
with 62% to 71% ethanol (rubbing) alcohol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite
26
(bleach) can inactivate the viruses within 60 seconds of contact time.
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PERSONAL PROTECTIVE EQUIPMENT
The CDC's Guidelines for Infection Control in Dental Health-Care Settings-2003 discuss the
use of PPE to prevent potentially infectious splash, spatter and aerosols generated during
25
rinsing, or when using handpieces and other devices (such as ultrasonic units). Employers
should select appropriate PPE and provide it to DHCP in accordance with the Occupational
27
Safety and Health Administration's PPE standards (29 CFR 1910 Subpart 7). Dental teams must
receive training and demonstrate an understanding of when to use PPE; what PPE is necessary;
how to properly don, use and doff PPE to prevent self-contamination; how to properly dispose
28' 29
of or disinfect and maintain PPE; and the limitations of protective equipment (Table 4).
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worn during procedures that involve possible aerosols, splash or spatter. According to the U.S.
Food and Drug Admi��Wa1filh?Jli.ft�fd�iY/3�e'm£;k tb<v9rls\h�'J1g� and mouth, and is

labeled as a surgical, laser, isolation, dental or medical procedure mask (with or without a face
30

shield).

There are multiple levels of mask protection for DHC P, each identified according to

bacterial filtration and particulate filtration efficiency levels that correspond to the demands of
28

a given dental procedure.

Health care and institutional settings use respirators that are at

least as protective as an N95 respirator before entry into the patient care area. Oral health
professionals working in facilities with high infectious disease transmission potential, such as
hospitals, long-term care facilities, and dental care units located in these type of settings, may
warrant use of an N95 respirator.

TABLE 4.

Persona l Protective Eq u i pment

Gloves
• Perform hand hygiene, then put on clea n , non-sterile gloves prior to patient care .
C hange gloves if they become torn or heavi ly contami nated.
• Remove and discard gloves when patient ca re is completed, and immediately
perform hand hyg iene.
Face Mask Protection 28
Level 1 masks provi de a protection va lue of 2: 95% bacterial fi ltration efficiency
(B FE) and pa rticu late fi ltration efficiency (PFE); these are su ita ble for brief
exa m i nations, exposi n g rad iographs a n d cleaning tasks.
Level 2 masks offer a moderate protection of 2: 98% BFE and PFE, and are
preferable fo r procedures that involve a moderate level of aerosols, such as hand
instru mentation or applyi ng sealants.
Level 3 masks offer a high level of protection of 2: 98 % BFE a nd PFE, a nd a re used
for procedures i nvolvi ng h igh levels of aerosols, such as ultrasonic scali n g, su rgical
proced u res and crown prepa ration .
Maxi mum fi ltration masks, such as a n N95 pa rticu late respi rator, feature 99. 9 %
PFE a n d are indicated when treating patients with a i rborne diseases.
Eye Protection
• Wear eye protection (e. g . , safety g lasses or a d isposable face shield that covers
the front and sides of the face) u pon entry to the patient care a rea .
• Remove eye protection before leaving the patient care area .
• Reusable eye p rotection (e . g ., safety g lasses) must be clea ned and disinfected
according to man ufactu rer's reprocessi ng instructions prior to reuse .
• D isposa ble eye protection should be d iscarded after use .
• Denta l lou pes must b e clean ed a n d disinfected between each patient to avoid
cross-conta mi nation risks. 2 9

S U M MARY
All health care personnel need to be prepared for, and remain informed about, COVID-79, its
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health professionals have a responsibility to be knowledgeable about infectious diseases.
Providers should also �� � � RRft:8Yt�fs¥8 H?��n�'i<tfmf cli�� to the highest

standards of infection control. B y maintaining a standard of care that is in accordance with CDC
guidelines, dental teams can effectively contribute to disease prevention and help slow the
coronavirus pandemic.
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